Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Stivarga
(https://stivarga.com) 📸 Data Snapshot: June 19, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Site Maintenance (https://stivarga.com)
Site Maintenance
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://stivarga.com) Site Maintenance
Your bot have been rated as a harmful activity and will be blocked to prevent potential damage, please get in touch with support team: to start registration process of a harmless bot. Please supply bot IP address: 77.37.37.89 and error code: 0.921e1202.1781898070.4f5286d7.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Stivarga has 0.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Stivarga (stivarga.com)
This is a digital ghost site that currently offers zero substance and serves only as a technical barrier. While it avoids the ‘hot air’ of marketing fluff, it fails every industry-specific requirement for transparency, authority, and clinical proof. The site is a pharmaceutical authority vacuum.
The technical team must immediately resolve the 403-error/bot-block to restore the site’s primary pharmaceutical content. Once restored, the homepage must be updated to include an H1 tag with clear, FDA-compliant indications for the product. Structured data, specifically MedicalWebPage or Drug schema, must be implemented to link to verified clinical trial data. Finally, the site must include a mandatory pharmacovigilance link for adverse event reporting to satisfy basic regulatory and industry trust standards.
The URL and meta-title indicate that this is the primary digital asset for Stivarga (regorafenib), a pharmaceutical product within the Biotech and Pharma industry. However, the available data shows a total mismatch between the expected professional medical resource and the actual content, which is a technical bot-blocking error page.
“The score of 40 reflects a 'Moderate BS' level, driven primarily by the Information Density and Identity/Authority pillars. The site is penalized for its total lack of industry substance and its technical failure to represent a regulated pharmaceutical entity. It does not reach the 'Extreme BS' range only because it lacks active, deceptive marketing hyperbole.”
This training module utilizes a snapshot of public data from Stivarga, captured on June 19, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Stivarga: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://stivarga.com to view the most current version of its content and learn from the source what this company is about and what it offers.